London Stock Exchange Group plc

Good morning and welcome to the investor and analyst call for ELSEG's 2024 full year results. At this time, all participants are in listen-only mode. Later, we will conduct a question and answer session through the phone lines and instructions will follow at that time. I would like to remind all participants that this call is being recorded. I will now hand over to David Schwimmer, Chief Executive Officer, to open the presentation.

Please go ahead. Good morning and welcome to our 2024 full year results.

I'm joined by Michelle Alain-Aproche, our MAP, our CFO, and by Peregrine Riviere, Head of Investor Relations. In 2024, HealthSafe made significant progress on our strategy as we continue to transform our business and the industry we serve with innovative products across the trade lifecycle. HealthSafe delivered a year of strong revenue growth up 8.4% or 7.7% on an organic basis. Our good performance was broad-based, driven by a high pace of innovation and relentless customer focus. We're also delivering efficient growth with 80 basis points of margin improvement in the year. Our equity free cash flow is up very strongly to 2.2 billion pounds, supporting significant shareholder returns and our continued investment in future growth. I'll come back to the commercial and strategic progress we're making in a moment. But first, I'll hand over to Matt to take you through our financial performance in more detail.